Financial Ratios

MAX HEALTHCARE INSTITUTE LTD.

NSE : MAXHEALTHBSE : 543220ISIN CODE : INE027H01010Industry : Hospital & Healthcare ServicesHouse : Max
BSE798.95-14 (-1.72 %)
PREV CLOSE ( ) 812.95
OPEN PRICE ( ) 815.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 50021
TODAY'S LOW / HIGH ( )796.90 815.75
52 WK LOW / HIGH ( )436.95 909
NSE803.45-7.55 (-0.93 %)
PREV CLOSE( ) 811.00
OPEN PRICE ( ) 810.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 803.45 (883)
VOLUME 1069386
TODAY'S LOW / HIGH( ) 796.50 814.95
52 WK LOW / HIGH ( )436.9 910
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)7.153.42-1.70-0.06-0.35
   CEPS(Rs)8.324.57-0.760.010.64
   DPS(Rs)1.000.000.000.000.00
   Book NAV/Share(Rs)72.1064.8661.2153.5223.95
   Tax Rate(%)-23.2917.22-12.284.52-33.55
Margin Ratios
   Core EBITDA Margin(%)30.6224.5115.61-10.073.30
   EBIT Margin(%)32.2925.88-3.3096.002.93
   Pre Tax Margin(%)29.5722.56-14.21-5.23-1.39
   PAT Margin (%)36.4518.67-15.95-4.99-1.86
   Cash Profit Margin (%)42.4024.98-7.150.663.40
Performance Ratios
   ROA(%)8.554.43-3.08-0.11-0.95
   ROE(%)10.455.43-3.74-0.14-1.44
   ROCE(%)8.657.07-0.692.181.75
   Asset Turnover(x)0.230.240.190.020.51
   Sales/Fixed Asset(x)0.400.460.650.161.57
   Working Capital/Sales(x)1.914.301.500.0323.93
Efficiency Ratios
   Fixed Capital/Sales(x)2.502.201.546.400.64
   Receivable days39.3659.4169.291137.4791.10
   Inventory Days5.234.747.610.005.97
   Payable days216.61159.70154.12324.92
Valuation Parameters
   PER(x)61.67101.460.000.000.00
   PCE(x)53.0275.85-270.060.000.00
   Price/Book(x)6.125.353.370.000.00
   Yield(%)0.230.000.00
   EV/Net Sales(x)22.0718.9619.0419.060.92
   EV/Core EBITDA(x)57.7258.9173.4018.7511.18
   EV/EBIT(x)68.3573.26-577.1019.8531.22
   EV/CE(x)4.994.312.750.320.47
   M Cap / Sales22.4818.9519.310.000.00
Growth Ratio
   Net Sales Growth(%)7.2872.231639.42-94.12-4.84
   Core EBITDA Growth(%)27.46113.67343.91-27.0651.04
   EBIT Growth(%)33.881450.84-159.7892.39403.75
   PAT Growth(%)109.43301.59-5455.7484.1846.39
   EPS Growth(%)109.15300.83-2989.8484.1846.38
Financial Stability Ratios
   Total Debt/Equity(x)0.060.070.060.230.30
   Current Ratio(x)3.262.383.504.151.13
   Quick Ratio(x)3.192.303.424.151.08
   Interest Cover(x)11.857.80-0.300.950.68
   Total Debt/Mcap(x)0.010.010.02

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.